CaboCHECK - Cabozantinib in Adult Patients With Advanced Renal Cell Carcinoma Following Prior Systemic Check Point Inhibition Therapy: a Retrospective, Non-interventional Study

Clinical trial NCT04147143 · TERMINATED

Trial details

NCT number: NCT04147143
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Status: TERMINATED
Study type: OBSERVATIONAL

Advanced Renal Cell Carcinoma (All Subtypes)Metastatic Renal Cell Carcinoma (All Subtypes)

Start date: 2019-03-08
Primary completion: 2021-02-28
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.